UnknownNot Applicable

Outcome of Balloon Pulmonary Valvuloplasty in Patients With Congenital Pulmonary Stenosis in Terms of Reverse Right Ventricular Remodelling and Functional Exercise Capacity

Egypt30 participantsStarted 2021-01-10

Plain-language summary

A prospective of 30 patients with symptomatic severe congenital valvular pulmonary stenosis who are indicated for percutaneous balloon pulmonary valvuloplasty . the aim is to 1. \- evaluate electrical and mechanical remodeling of RV 6 months following balloon dilation 2. \- evaluate Functional capacity using 6MWT and SaO2 before and 6 months following BPV

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Patients with isolated supra-valvular and sub valvular pulmonary stenosis
✕. Patients with peripheral pulmonary stenosis.
✕. Patients with pulmonary stenosis if part of another congenital heart disease .
✕. Patients with organically diseased Tricuspid valve
✕. Patients with any significant shunt lesion which result in dilation in RV such as atrial septal defect.
✕. Patients with right ventricular dysfunction due to arrhythmogenic right ventricular dysplasia (ARVD) or non compaction

What they're measuring

reverse Right ventricular remodeling

Timeframe: one year

functional exercise capacity

Timeframe: one year

Trial details

NCT IDNCT05828524

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12

View on ClinicalTrials.gov More Congenital Heart Disease trials